Greenphire unveils patient-facing digital platform GreenSpace
Greenphire, the King of Prussia-based global leader in patient convenience and financial lifecycle management for clinical trials, today unveiled a new patient-facing digital platform, GreenSpace, coupled with increased international payment functionality and flexibility, dramatically improving access, engagement, and retention globally.
The full news and details can be found here: https://prn.to/3V543ME
WHY IT MATTERS:
Clinical trials are critical to bringing new drugs and/or treatments to prevent, detect, or treat existing or new diseases. Yet, participation remains low due to barriers, such as time, travel, and out-of-pocket costs, which continue to keep patients from participating. What’s more:
- 80% of individuals say that availability of mobile applications is an important factor when deciding to participate in a clinical trial (2021 CISCRP study)
- A recent survey found that 82% of sites said that delays in site payments from study sponsors have a direct negative impact on their business operations.
Greenphire has expanded its proven global payment offerings available through ClinCard, the industry’s leading technology for international patient reimbursement automation. With the continued goal of supporting patients’ requirements and preferences anywhere in the world, the solution will offer a comprehensive suite of payment modalities for both banked and unbanked study populations.
GreenSpace enhances the trial experience for participants around the world. Unlike other solutions available in the market today, GreenSpace offers a unified digital experience accessible via iOS and Android devices, or through an internet browser. The comprehensive platform provides easy access to trial-related information and activities such as financial views and account details, submission of receipts for reimbursement, visit and travel itinerary details, delivery of surveys and insights and more.
